Recap: Coherus BioSciences Q1 Earnings

Coherus BioSciences CHRS reported its Q1 earnings results on Thursday, May 5, 2022 at 05:01 PM.

Here's what investors need to know about the announcement.

Earnings

Coherus BioSciences missed estimated earnings by 108.33%, reporting an EPS of $-1.0 versus an estimate of $-0.48.

Revenue was down $22.92 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.05 which was followed by a 4.12% drop in the share price the next day.

Here's a look at Coherus BioSciences's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.51 -0.22 -0.17 0.06
EPS Actual -0.46 -0.34 -0.36 0.01
Revenue Estimate 85.81M 91.31M 89.81M 96.00M
Revenue Actual 73.37M 82.50M 87.64M 83.03M

To track all earnings releases for Coherus BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!